Literature DB >> 15635266

Activation of c-kit by stem cell factor induces radioresistance to apoptosis through ERK-dependent expression of survivin in HL60 cells.

Seyed Jalal Hosseinimehr1, Osamu Inanami, Taku Hamasu, Momoko Takahashi, Ikuo Kashiwakura, Taketoshi Asanuma, Mikinori Kuwabara.   

Abstract

We investigated the effect of SCF, a c-kit ligand, on the radiosensitivity of HL60 cells. X-ray-induced apoptosis in HL60 cells was significantly lower in the presence of SCF than in the absence of SCF. This attenuation of X-ray-induced apoptosis by SCF was abolished by PD98059 (an ERK inhibitor), but not by wortmannin (a PI3-K inhibitor) or GF109203X (a PKC inhibitor). The expression of phospho-ERK1/2 (active form) and the ERK1/2-regulated expression of survivin were found to increase in cells treated with X irradiation and SCF. However, X irradiation alone induced down-regulation of the expression of phospho-ERK1/2. Our findings suggest that activation of c-kit by SCF confers radioresistance through up-regulation of ERK-dependent survivin expression in HL60 cells.

Entities:  

Mesh:

Substances:

Year:  2004        PMID: 15635266     DOI: 10.1269/jrr.45.557

Source DB:  PubMed          Journal:  J Radiat Res        ISSN: 0449-3060            Impact factor:   2.724


  9 in total

1.  Suppressive effects of liquid crystal compounds on the growth of the A549 human lung cancer cell line.

Authors:  Yuuka Takahashi; Masaharu Hazawa; Kenji Takahashi; Ayumi Nishizawa; Atsushi Yoshizawa; Ikuo Kashiwakura
Journal:  Invest New Drugs       Date:  2010-03-17       Impact factor: 3.850

2.  Multicenter prospective trial of hypofractionated radiation treatment, toceranib, and prednisone for measurable canine mast cell tumors.

Authors:  K S Carlsten; C A London; S Haney; R Burnett; A C Avery; D H Thamm
Journal:  J Vet Intern Med       Date:  2011-12-19       Impact factor: 3.333

3.  Survivin inhibition is critical for Bcl-2 inhibitor-induced apoptosis in hepatocellular carcinoma cells.

Authors:  Xiangxuan Zhao; Olorunseun O Ogunwobi; Chen Liu
Journal:  PLoS One       Date:  2011-08-01       Impact factor: 3.752

4.  Structure-activity relationships between the Aconitum C20-diterpenoid alkaloid derivatives and the growth suppressive activities of Non-Hodgkin's lymphoma Raji cells and human hematopoietic stem/progenitor cells.

Authors:  Masaharu Hazawa; Kenji Takahashi; Koji Wada; Takao Mori; Norio Kawahara; Ikuo Kashiwakura
Journal:  Invest New Drugs       Date:  2009-09-26       Impact factor: 3.850

5.  Hematopoietic stem cell responsiveness to exogenous signals is limited by caspase-3.

Authors:  Viktor Janzen; Heather E Fleming; Tamara Riedt; Göran Karlsson; Matthew J Riese; Cristina Lo Celso; Griffin Reynolds; Craig D Milne; Christopher J Paige; Stefan Karlsson; Minna Woo; David T Scadden
Journal:  Cell Stem Cell       Date:  2008-06-05       Impact factor: 24.633

6.  Suppressive effects of novel derivatives prepared from Aconitum alkaloids on tumor growth.

Authors:  Masaharu Hazawa; Koji Wada; Kenji Takahashi; Takao Mori; Norio Kawahara; Ikuo Kashiwakura
Journal:  Invest New Drugs       Date:  2008-06-13       Impact factor: 3.850

7.  Suppressive effects of liquid crystal compounds on the growth of U937 human leukemic monocyte lymphoma cells.

Authors:  Junya Ishikawa; Yuuka Takahashi; Masaharu Hazawa; Yukako Fukushi; Atsushi Yoshizawa; Ikuo Kashiwakura
Journal:  Cancer Cell Int       Date:  2012-02-03       Impact factor: 5.722

Review 8.  Receptor tyrosine kinase (c-Kit) inhibitors: a potential therapeutic target in cancer cells.

Authors:  Maryam Abbaspour Babaei; Behnam Kamalidehghan; Mohammad Saleem; Hasniza Zaman Huri; Fatemeh Ahmadipour
Journal:  Drug Des Devel Ther       Date:  2016-08-01       Impact factor: 4.162

Review 9.  The paradox role of caspase cascade in ionizing radiation therapy.

Authors:  Najmeh Rahmanian; Seyed Jalal Hosseinimehr; Ali Khalaj
Journal:  J Biomed Sci       Date:  2016-12-07       Impact factor: 8.410

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.